• Product NameZaprinast
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityZaprinast was an unsuccessful clinical drug candidate that was a precursor to the chemically related PDE5 inhibitors, such as sildenafil (Viagra), which successfully reached the market.
• Target NamePDE inhibitor
• CAS No. 37762-06-4
• Calculated MW 271.27
• Formulation C13H13N5O2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Respiratory system
  SMILES:CCCOC1=CC=CC=C1C1=NC(=O)C2=NNNC2=N1
  Pathways:Metabolism
  Receptor:PDE
  Boling pt:
  Melting pt:
  Solubility:Soluble in DMSO
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Taniguchi Y, et al. FEBS Lett. 2006 Sep 18;580(21):5003-8.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting